Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 35.85 is 47% above its 1-year average of 24.35, near the high end of its 1-year range (12.85–35.85).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation.
Limited quarterly history available
Current Ratio needs at least three reported quarters before a meaningful chart is shown.
CURRENT RATIO
35.85
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.49
median of 707 covered companies
CURRENT VS SECTOR MEDIAN
+927.12%
vs the sector median at left
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.37B
Current Ratio
35.85
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.41B
Current Ratio
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$1.44B
Current Ratio
1.73
TTM Avg
2.42
3Y Avg
2.71
5Y Avg
3.73
Market Cap
$1.46B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.37B | 35.85 | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.35B | 1.95 | 2.22 | 2.95 | 3.45 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | 11.11 | 12.01 | 12.01 | 12.01 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.41B | 5.07 | 3.94 | 5.82 | 5.62 |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 1.20 | 1.17 | 1.13 | 1.04 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.33B | 11.09 | 7.43 | 12.87 | 13.60 |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 5.61 | 9.29 | 11.65 | 16.84 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | 1.73 | 2.42 | 2.71 | 3.73 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 3.02 | 3.13 | 2.94 | 3.03 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
Current Ratio
35.85
Quick Ratio
35.85
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 35.85 |
| 2026-03-31 | 12.85 |
